GlassScriptPhysician profile
Allan M Ramirez
NPI 1457389280
$10,965.36
in general payments reported to CMS, 2019-2025
34 companies · $1,583 in 2025
The $1,583 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,208 · 2020: $779 · 2021: $1,125 · 2022: $1,150 · 2023: $1,553 · 2024: $1,568 · 2025: $1,583.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,703.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pari Respiratory Equipment, INC. | $1,627.50 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $1,565.74 | 2020-2025 | Fasenra, Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,002.91 | 2019-2025 | Ofev |
| United Therapeutics Corporation | $796.89 | 2022-2025 | Tyvaso |
| Pulmonx Corporation | $757.94 | 2019-2022 | |
| Mylan Specialty L.P. | $502.59 | 2022-2024 | Tobi Podhaler |
| Gilead Sciences, INC. | $455.81 | 2019-2021 | |
| Insmed, INC. | $375.90 | 2019-2021 | |
| Nabriva Therapeutics, Plc | $370.52 | 2020 | |
| Abbvie INC. | $338.78 | 2022-2025 | |
| Astellas Pharma US INC | $306.36 | 2019-2025 | Cresemba |
| Baxter Healthcare | $269.65 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Volara System |
| Mallinckrodt Hospital Products INC. | $265.13 | 2024-2025 | Acthar |
| Veloxis Pharmaceuticals, INC. | $241.89 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $235.46 | 2023-2024 | Livtencity |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viatris Specialty LLC | $179.08 | 2025 | Tobi Podhaler |
| Axogen | $139.73 | 2023 | Avance Nerve Graft |
| Genzyme Corporation | $133.24 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $128.63 | 2023-2025 | Trikafta |
| Boston Scientific Corporation | $124.03 | 2021 | |
| Alexion Pharmaceuticals, INC. | $121.46 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $119.70 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $119.70 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $119.70 | 2025 | Uptravi, Opsumit |
| Advanced Respiratory, INC | $105.32 | 2019-2020 | |
| Shionogi INC | $101.73 | 2025 | Fetroja |
| Merck Sharp & Dohme LLC | $95.18 | 2025 | Zerbaxa |
| Tetraphase Pharmaceuticals, INC. | $86.36 | 2019 | |
| Zambon USA LTD. | $71.03 | 2024 | |
| Digestive Care, INC. | $69.30 | 2025 | Pertzye |
| Chiesi USA, INC. | $49.90 | 2022-2023 | Bronchitol |
| Electromed, INC. | $43.41 | 2025 | Smartvest |
| Csl Behring | $26.75 | 2019 | |
| Genentech USA, INC. | $18.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allan Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.